R. Uzawa, K. Su, Taiichiro Kobayashi, Hiroyuki Watanabe, K. Fukuchi, Y. Takagi, K. Gomi, Chang Gu Kang
{"title":"ANP和BNP抑制培养的牛肾上腺肾小球细胞分泌醛固酮的作用机制","authors":"R. Uzawa, K. Su, Taiichiro Kobayashi, Hiroyuki Watanabe, K. Fukuchi, Y. Takagi, K. Gomi, Chang Gu Kang","doi":"10.14921/JSCC1971B.22.3_156","DOIUrl":null,"url":null,"abstract":"Atrial natriuretic peptide (ANP) (10-8mol/l), brain natriuretic peptide (BNP) (10-8mol/l), the protein kinase C (PKC) inhibitors H-7 (10-5mol/l) and staurosporin (10-8mol/l) suppressed aldosterone secretion in cultured bovine adrenal glomerulosa cells by 40 to 50 % compared with untreated control cells. When cells incubated with 10-8mol/l angiotensin II (All) were also treated with ANP, BNP, or PKC inhibitors, aldosterone secretion was 50 to 60 % of that seen in untreated cells. ANP, BNP and PKC inhibitors suppressing the expression of PKC, suggested that PKC plays a role in aldosterone secretion. Our results suggest that ANP and BNP may have an unknown second messenger pathway in which the suppression of PKC is essential for the ex-","PeriodicalId":39360,"journal":{"name":"Japanese Journal of Clinical Chemistry","volume":"22 1","pages":"156-161"},"PeriodicalIF":0.0000,"publicationDate":"1993-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mechanism of ANP and BNP Action on the Suppression of Aldosterone Secretion by Cultured Bovine Adrenal Glomerulosa Cells\",\"authors\":\"R. Uzawa, K. Su, Taiichiro Kobayashi, Hiroyuki Watanabe, K. Fukuchi, Y. Takagi, K. Gomi, Chang Gu Kang\",\"doi\":\"10.14921/JSCC1971B.22.3_156\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atrial natriuretic peptide (ANP) (10-8mol/l), brain natriuretic peptide (BNP) (10-8mol/l), the protein kinase C (PKC) inhibitors H-7 (10-5mol/l) and staurosporin (10-8mol/l) suppressed aldosterone secretion in cultured bovine adrenal glomerulosa cells by 40 to 50 % compared with untreated control cells. When cells incubated with 10-8mol/l angiotensin II (All) were also treated with ANP, BNP, or PKC inhibitors, aldosterone secretion was 50 to 60 % of that seen in untreated cells. ANP, BNP and PKC inhibitors suppressing the expression of PKC, suggested that PKC plays a role in aldosterone secretion. Our results suggest that ANP and BNP may have an unknown second messenger pathway in which the suppression of PKC is essential for the ex-\",\"PeriodicalId\":39360,\"journal\":{\"name\":\"Japanese Journal of Clinical Chemistry\",\"volume\":\"22 1\",\"pages\":\"156-161\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1993-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Clinical Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14921/JSCC1971B.22.3_156\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Clinical Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14921/JSCC1971B.22.3_156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Mechanism of ANP and BNP Action on the Suppression of Aldosterone Secretion by Cultured Bovine Adrenal Glomerulosa Cells
Atrial natriuretic peptide (ANP) (10-8mol/l), brain natriuretic peptide (BNP) (10-8mol/l), the protein kinase C (PKC) inhibitors H-7 (10-5mol/l) and staurosporin (10-8mol/l) suppressed aldosterone secretion in cultured bovine adrenal glomerulosa cells by 40 to 50 % compared with untreated control cells. When cells incubated with 10-8mol/l angiotensin II (All) were also treated with ANP, BNP, or PKC inhibitors, aldosterone secretion was 50 to 60 % of that seen in untreated cells. ANP, BNP and PKC inhibitors suppressing the expression of PKC, suggested that PKC plays a role in aldosterone secretion. Our results suggest that ANP and BNP may have an unknown second messenger pathway in which the suppression of PKC is essential for the ex-